These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26400565)

  • 1. [Cell death in malignant tumors. Relevance of cell death regulation for metastasis].
    Roth W
    Pathologe; 2015 Nov; 36 Suppl 2():181-4. PubMed ID: 26400565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
    Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells.
    Yu W; Xu YC; Tao Y; He P; Li Y; Wu T; Zhu YP; Li J; Wu JX; Dai J
    Oncol Rep; 2013 Dec; 30(6):2741-8. PubMed ID: 24101127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review).
    Song Q; Ji Q; Li Q
    Int J Mol Med; 2018 Feb; 41(2):631-639. PubMed ID: 29207104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling.
    Ishikawa F; Ushida K; Mori K; Shibanuma M
    Cell Death Dis; 2015 Jan; 6(1):e1619. PubMed ID: 25611393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.
    Ge Z; Sanders AJ; Ye L; Wang Y; Jiang WG
    J Exp Ther Oncol; 2011; 9(2):109-18. PubMed ID: 21699018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients.
    Tu HF; Liu CJ; Liu SY; Chen YP; Yu EH; Lin SC; Chang KW
    Head Neck; 2011 Mar; 33(3):396-402. PubMed ID: 20645287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.
    Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z
    J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-driven selection of the metastatic phenotype.
    Sullivan R; Graham CH
    Cancer Metastasis Rev; 2007 Jun; 26(2):319-31. PubMed ID: 17458507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
    Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
    Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.
    Strilic B; Yang L; Albarrán-Juárez J; Wachsmuth L; Han K; Müller UC; Pasparakis M; Offermanns S
    Nature; 2016 Aug; 536(7615):215-8. PubMed ID: 27487218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W; Zhang C; Chen C; Zhuang G
    Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasion and metastasis--recent advances and future challenges.
    Chambers AF; Werb Z
    J Mol Med (Berl); 2015 Apr; 93(4):361-8. PubMed ID: 25772709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.